drugset / Trial / NCT02985827

Symptom Response in Normal and Dry Eye Patients Secondary to Application of a Menthol-Containing Eyedrop (Rohto® Hydra)

NCT02985827 ↗

Phase 4 Completed 48 enrolled ORA, Inc.
RandomizedCrossoverSingle-blindBasic science

Summary

The purpose of the study is to analyze the sensation to eye drops containing menthol in people with healthy eyes and in people with dry eyes. This study also examines the temperature of your eye using an Infrared Camera.

Timeline

Start
2015-12
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rohto (r) Hydra Unknown 0.01 % Topical

Indications